Bank of New York Mellon Corp - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 12 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$347,000
-10.6%
216,8970.0%0.00%
Q3 2019$388,000
+41.6%
216,8970.0%0.00%
Q2 2019$274,000
+52.2%
216,897
+120.4%
0.00%
Q1 2019$180,00098,3960.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS (UK) LLP 1,596,666$2,858,0000.08%
Polar Capital LLP 300,000$537,0000.01%
Larson Financial Group LLC 654$1,0000.00%
ACADIAN ASSET MANAGEMENT LLC 173,385$310,0000.00%
Bank of New York Mellon Corp 216,897$388,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,491$47,0000.00%
Parkside Financial Bank & Trust 398$1,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
MORGAN STANLEY 227,960$408,0000.00%
Renaissance Technologies 112,106$201,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders